A new entity of abdominal squamous cell carcinoma of unknown primary-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A new entity of abdominal squamous cell carcinoma of unknown primary

Published:2019-04-15 Issue:7 Volume:49 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

El Rassy Elie¹²^ORCID,Kattan Joseph²,Pavlidis Nicholas³

Affiliation:

1. Department of Cancer Medicine Gustave Roussy Institute Villejuif France

2. Department of Hematology‐Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine Saint Joseph University Beirut Lebanon

3. University of Ioannina Ioannina Greece

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13111

Reference31 articles.

1. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Forty years experience of treating cancer of unknown primary

3. Diagnostic and therapeutic management of cancer of an unknown primary

4. The current evidence for a biomarker-based approach in cancer of unknown primary

5. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HPV-related metastatic retroperitoneal pelvic squamous cell carcinoma of unknown primary origin in a patient previously treated for endometrial cancer;International Journal of Surgery Case Reports;2024-05

2. Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center;International Journal of Clinical Oncology;2023-03-10

3. The diagnosis and treatment for a patient with cancer of unknown primary: A case report;Frontiers in Genetics;2023-01-19

4. A case of refractory pelvic squamous cell carcinoma of unknown primary that responded to nivolumab;Journal of Obstetrics and Gynaecology Research;2023-01-05

5. Systematic review of the CUP trials characteristics and perspectives for next-generation studies;Cancer Treatment Reviews;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3